Sangamo Therapeutics Inc (NASDAQ:SGMO)

19.05
Delayed Data
As of Apr 20
 -0.15 / -0.78%
Today’s Change
4.05
Today|||52-Week Range
27.50
+16.16%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 32.50, with a high estimate of 39.00 and a low estimate of 8.00. The median estimate represents a +70.60% increase from the last price of 19.05.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$8.7M
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -48.33%
 
 
 
 
 
 
Growthannually 104.76%
 
 
 
 
 
 

Sales

Growthquarterly -33.64%
 
 
 
 
 
 
Growthannually 209.89%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.